Labeler
Sanofi-Aventis U.S. LLC NDC Codes
Sanofi-Aventis U.S. LLC lists 81 finished drug products in the FDA NDC Directory under NDC labeler codes 0024, 0068, 0075, 0088, 0955.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Lovenox, Enoxaparin sodium, Sevelamer Carbonate, Dupixent, Kevzara, Admelog, Docetaxel, Arava, Merilog, Sarclisa, Praluent, Ferrlecit, Avapro, Avalide, Zaltrap
- Active ingredients
- Enoxaparin sodium, Insulin glargine, Sevelamer carbonate, Dupilumab, Sarilumab, Irbesartan, Isatuximab, Insulin lispro, Docetaxel, Leflunomide, Insulin aspart, Alirocumab
- NDC labeler codes
- 0024, 0068, 0075, 0088, 0955
- Strengths
- Insulin lispro 100 U/mL; Enoxaparin sodium 30 mg/.3mL; Enoxaparin sodium 40 mg/.4mL; Enoxaparin sodium 60 mg/.6mL; Enoxaparin sodium 80 mg/.8mL; Enoxaparin sodium 100 mg/mL; Enoxaparin sodium 120 mg/.8mL; Enoxaparin sodium 150 mg/mL; Enoxaparin sodium 300 mg/3mL; Insulin aspart 100 [iU]/mL; Sevelamer carbonate 800 mg/1; Insulin glargine 300 [iU]/mL; Dupilumab 200 mg/1.14mL; Dupilumab 300 mg/2mL; Sarilumab 150 mg/1.14mL; Sarilumab 200 mg/1.14mL; Insulin glargine 300 U/mL; Sodium ferric gluconate complex 12.5 mg/mL; Irbesartan 150 mg/1; Irbesartan 300 mg/1
- Dosage forms
- Injection, Solution, Injection, Tablet, Film coated, Injection, Solution, Concentrate, Kit, Powder, For suspension, Solution, Concentrate, Tablet
- Routes
- Subcutaneous, Oral, Intravenous
- Drug classes (FDA established)
- Low Molecular Weight Heparin, Insulin Analog, Phosphate Binder, Interleukin-4 Receptor alpha Antagonist, Interleukin-6 Receptor Antagonist, Angiotensin 2 Receptor Blocker, CD38-directed Cytolytic Antibody, Microtubule Inhibitor, Antirheumatic Agent, PCSK9 Inhibitor, Parenteral Iron Replacement, Thiazide Diuretic, Vascular Endothelial Growth Factor Inhibitor, P2Y12 Platelet Inhibitor, Nitroimidazole Antimicrobial, Rifamycin Antimycobacterial, GLP-1 Receptor Agonist, Hematopoietic Stem Cell Mobilizer, Antimalarial, Antiarrhythmic, gamma-Aminobutyric Acid A Receptor Positive Modulator
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 102
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Rifadinrifampicin | — | Kit | 0068-0660 | 00068-0660-50 | — |
| Sarclisa Escenaisatuximab-irfc | Isatuximab 140 mg/mL | Injection, SolutionSubcutaneous | 0024-0674 | 00024-0674-01 | — |
| Meriloginsulin aspart-szjj | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | 0024-5927 | 00024-5927-00 | — |
| Meriloginsulin aspart-szjj | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | 0024-5928 | 00024-5928-05 | — |
| Sevelamer Carbonate | Sevelamer carbonate 800 mg/1 | Tablet, Film coatedOral | 0955-1057 | 00955-1057-30 | — |
| Insulin glargine U-300 Maxinsulin glargine | Insulin glargine 300 [iU]/mL | Injection, SolutionSubcutaneous | 0955-2900 | 00955-2900-02 | — |
| Insulin glargine U-300insulin glargine | Insulin glargine 300 [iU]/mL | Injection, SolutionSubcutaneous | 0955-3900 | 00955-3900-03 | — |
| Fexinidazole | Fexinidazole 600 mg/1 | TabletOral | 0024-4512 | 00024-4512-1400024-4512-24 | — |
| Dupixentdupilumab | Dupilumab 200 mg/1.14mL | Injection, SolutionSubcutaneous | 0024-5919 | 00024-5919-0200024-5919-20 | — |
| Dupixentdupilumab | Dupilumab 300 mg/2mL | Injection, SolutionSubcutaneous | 0024-5915 | 00024-5915-0200024-5915-20 | — |
| Sarclisaisatuximab | Isatuximab 100 mg/5mL | Injection, Solution, ConcentrateIntravenous | 0024-0654 | 00024-0654-01 | — |
| Sarclisaisatuximab | Isatuximab 500 mg/25mL | Injection, Solution, ConcentrateIntravenous | 0024-0656 | 00024-0656-01 | — |
| Dupixentdupilumab | Dupilumab 200 mg/1.14mL | Injection, SolutionSubcutaneous | 0024-5918 | 00024-5918-0100024-5918-02 | — |
| Admeloginsulin lispro | Insulin lispro 100 U/mL | Injection, SolutionIntravenous, Subcutaneous | 0024-5926 | 00024-5926-05 | — |
| Sevelamer Carbonate | Sevelamer carbonate 800 mg/1 | Tablet, Film coatedOral | 0955-1050 | 00955-1050-27 | — |
| Sevelamer Carbonate | Sevelamer carbonate .8 g/1 | Powder, For suspensionOral | 0955-1052 | 00955-1052-90 | — |
| Sevelamer Carbonate | Sevelamer carbonate 2.4 g/1 | Powder, For suspensionOral | 0955-1054 | 00955-1054-90 | — |
| Admeloginsulin lispro | Insulin lispro 100 U/mL | Injection, SolutionIntravenous, Subcutaneous | 0024-5924 | 00024-5924-10 | — |
| Admeloginsulin lispro | Insulin lispro 100 U/mL | Injection, SolutionSubcutaneous | 0024-5925 | 00024-5925-0000024-5925-05 | — |
| Kevzarasarilumab | Sarilumab 150 mg/1.14mL | Injection, SolutionSubcutaneous | 0024-5908 | 00024-5908-0100024-5908-02 | — |
| Kevzarasarilumab | Sarilumab 200 mg/1.14mL | Injection, SolutionSubcutaneous | 0024-5910 | 00024-5910-0100024-5910-02 | — |
| Kevzarasarilumab | Sarilumab 150 mg/1.14mL | Injection, SolutionSubcutaneous | 0024-5920 | 00024-5920-0100024-5920-02 | — |
| Kevzarasarilumab | Sarilumab 200 mg/1.14mL | Injection, SolutionSubcutaneous | 0024-5922 | 00024-5922-0100024-5922-02 | — |
| Dupixentdupilumab | Dupilumab 300 mg/2mL | Injection, SolutionSubcutaneous | 0024-5914 | 00024-5914-0100024-5914-02 | — |
| Priftinrifapentine | Rifapentine 150 mg/1 | Tablet, Film coatedOral | 0088-2102 | 00088-2102-24 | — |
| Soliqua 100/33insulin glargine and lixisenatide | Insulin glargine 100 U/mL; Lixisenatide 33 ug/mL | Injection, SolutionSubcutaneous | 0024-5761 | 00024-5761-0100024-5761-05 | — |
| Docetaxel | Docetaxel 160 mg/8mL | Injection, Solution, ConcentrateIntravenous | 0955-1022 | 00955-1022-08 | — |
| Praluentalirocumab | Alirocumab 75 mg/mL | Injection, SolutionSubcutaneous | 0024-5901 | 00024-5901-0000024-5901-01 | — |
| Praluentalirocumab | Alirocumab 150 mg/mL | Injection, SolutionSubcutaneous | 0024-5902 | 00024-5902-0000024-5902-01 | — |
| Toujeoinsulin glargine | Insulin glargine 300 U/mL | Injection, SolutionSubcutaneous | 0024-5869 | 00024-5869-0000024-5869-03 | — |
| TOUJEO Maxinsulin glargine | Insulin glargine 300 U/mL | Injection, SolutionSubcutaneous | 0024-5871 | 00024-5871-0100024-5871-02 | — |
| Ferrlecitsodium ferric gluconate complex | Sodium ferric gluconate complex 12.5 mg/mL | InjectionIntravenous | 0024-2794 | 00024-2794-10 | — |
| Mozobilplerixafor | Plerixafor 24 mg/1.2mL | Injection, SolutionSubcutaneous | 0024-5862 | 00024-5862-01 | — |
| Avaproirbesartan | Irbesartan 150 mg/1 | Tablet, Film coatedOral | 0024-5851 | 00024-5851-30 | — |
| Avaproirbesartan | Irbesartan 300 mg/1 | Tablet, Film coatedOral | 0024-5852 | 00024-5852-30 | — |
| Avalideirbesartan and hydrochlorothiazide | Irbesartan 150 mg/1; Hydrochlorothiazide 12.5 mg/1 | Tablet, Film coatedOral | 0024-5855 | 00024-5855-30 | — |
| Avalideirbesartan and hydrochlorothiazide | Irbesartan 300 mg/1; Hydrochlorothiazide 12.5 mg/1 | Tablet, Film coatedOral | 0024-5856 | 00024-5856-30 | — |
| Zaltrapziv-aflibercept | Aflibercept 100 mg/4mL | Solution, ConcentrateIntravenous | 0024-5840 | 00024-5840-01 | — |
| Zaltrapziv-aflibercept | Aflibercept 200 mg/8mL | Solution, ConcentrateIntravenous | 0024-5841 | 00024-5841-01 | — |
| Enoxaparin sodium | Enoxaparin sodium 30 mg/.3mL | InjectionSubcutaneous | 0955-1003 | 00955-1003-10 | — |
| Enoxaparin sodium | Enoxaparin sodium 40 mg/.4mL | InjectionSubcutaneous | 0955-1004 | 00955-1004-10 | — |
| Enoxaparin sodium | Enoxaparin sodium 60 mg/.6mL | InjectionSubcutaneous | 0955-1006 | 00955-1006-10 | — |
| Enoxaparin sodium | Enoxaparin sodium 80 mg/.8mL | InjectionSubcutaneous | 0955-1008 | 00955-1008-10 | — |
| Enoxaparin sodium | Enoxaparin sodium 100 mg/mL | InjectionSubcutaneous | 0955-1010 | 00955-1010-10 | — |
| Enoxaparin sodium | Enoxaparin sodium 120 mg/.8mL | InjectionSubcutaneous | 0955-1012 | 00955-1012-10 | — |
| Enoxaparin sodium | Enoxaparin sodium 150 mg/mL | InjectionSubcutaneous | 0955-1015 | 00955-1015-10 | — |
| Enoxaparin sodium | Enoxaparin sodium 300 mg/3mL | InjectionSubcutaneous | 0955-1016 | 00955-1016-01 | — |
| Primaquine Phosphate | Primaquine phosphate 15 mg/1 | Tablet, Film coatedOral | 0024-1596 | 00024-1596-01 | — |
| Ferrlecitsodium ferric gluconate complex | Sodium ferric gluconate complex 12.5 mg/mL | InjectionIntravenous | 0024-2792 | 00024-2792-10 | — |
| Docetaxel | Docetaxel 20 mg/mL | Injection, Solution, ConcentrateIntravenous | 0955-1020 | 00955-1020-01 | — |
Sanofi-Aventis U.S. LLC: common questions
- What is Sanofi-Aventis U.S. LLC's NDC labeler code?
- 0024, 0068, 0075, 0088, 0955. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Sanofi-Aventis U.S. LLC?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.